Epithelial-mesenchymal transition phenotype is associated with patient survival in small intestinal adenocarcinoma
- 1 October 2013
- Vol. 45 (6) , 567-573
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Epithelial-mesenchymal transition expression profiles as a prognostic factor for disease-free survival in hepatocellular carcinoma: Clinical significance of transforming growth factor-β signalingOncology Letters, 2012
- Vimentin in cancer and its potential as a molecular target for cancer therapyCellular and Molecular Life Sciences, 2011
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Biomarkers for epithelial-mesenchymal transitionsJournal of Clinical Investigation, 2009
- The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancerBritish Journal of Cancer, 2008
- Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteinsJournal of Cellular Biochemistry, 2007
- Fibronectin Stimulates Non–Small Cell Lung Carcinoma Cell Growth through Activation of Akt/Mammalian Target of Rapamycin/S6 Kinase and Inactivation of LKB1/AMP-Activated Protein Kinase Signal PathwaysCancer Research, 2006
- Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinaseCancer Letters, 2005
- Fibronectin stimulates human lung carcinoma cell growth by inducing cyclooxygenase‐2 (COX‐2) expressionInternational Journal of Cancer, 2004
- Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progressionEuropean Journal of Cancer, 2002